Cue Biopharma, Inc. — All Filings
479 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B1
424B3
424B5
424B7
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0000950170-24-056838 | May 9, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0000950170-24-056848 | May 9, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-049044 | Apr 26, 2024 | — |
| DEF 14A | DEF 14A | 0000950170-24-049072 | Apr 26, 2024 | Jun 5, 2024 |
| ARS | ARS | 0000950170-24-049039 | Apr 26, 2024 | Dec 31, 2023 |
| 10-K | 10-K | 0000950170-24-038059 | Mar 28, 2024 | Dec 31, 2023 |
| S-8 | S-8 | 0000950170-24-038084 | Mar 28, 2024 | — |
| SC 13G | CUEBIOPHARMA13G | 0001781002-24-000025 | Mar 11, 2024 | — |
| 4 | 4 | 0000950170-24-028611 | Mar 8, 2024 | Mar 6, 2024 |
| 4 | 4 | 0000950170-24-028613 | Mar 8, 2024 | Mar 6, 2024 |
| 4 | 4 | 0000950170-24-028612 | Mar 8, 2024 | Mar 6, 2024 |
| 4 | 4 | 0000950170-24-028608 | Mar 8, 2024 | Mar 6, 2024 |
| 4 | 4 | 0000950170-24-028609 | Mar 8, 2024 | Mar 6, 2024 |
| 4 | 4 | 0000950170-24-018724 | Feb 22, 2024 | Feb 20, 2024 |
| SC 13G | — | 0001086364-24-006803 | Feb 7, 2024 | — |
| SC 13G | — | 0001086364-24-006036 | Jan 31, 2024 | — |
| 4 | 4 | 0000950170-24-001833 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | 4 | 0000950170-24-001829 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | 4 | 0000950170-24-001827 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | 4 | 0000950170-24-001828 | Jan 4, 2024 | Jan 2, 2024 |
| 4 | 4 | 0000950170-24-001830 | Jan 4, 2024 | Jan 2, 2024 |
| 10-Q | 10-Q | 0000950170-23-058838 | Nov 3, 2023 | Sep 30, 2023 |
| 8-K | 8-K | 0001193125-23-235298 | Sep 14, 2023 | Sep 12, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-047575 | Aug 29, 2023 | Aug 25, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-046000 | Aug 16, 2023 | Aug 14, 2023 |
| 10-Q | 10-Q | 0000950170-23-039770 | Aug 8, 2023 | Jun 30, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-043276 | Jul 25, 2023 | Jul 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-043273 | Jul 25, 2023 | Jul 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-043277 | Jul 25, 2023 | Jul 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-043278 | Jul 25, 2023 | Jul 21, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-043274 | Jul 25, 2023 | Jul 21, 2023 |
| 8-K | 8-K | 0001193125-23-164491 | Jun 9, 2023 | Jun 7, 2023 |
| EFFECT | — | 9999999995-23-001552 | May 26, 2023 | — |
| CORRESP | — | 0001193125-23-152982 | May 24, 2023 | — |
| UPLOAD | — | 0000000000-23-005199 | May 16, 2023 | — |
| S-3 | S-3 | 0001193125-23-139563 | May 9, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-019646 | May 9, 2023 | Mar 31, 2023 |
| DEF 14A | DEF 14A | 0001193125-23-126883 | Apr 28, 2023 | Jun 7, 2023 |
| DEFA14A | DEFA14A | 0001193125-23-126907 | Apr 28, 2023 | — |
| ARS | ARS | 0001193125-23-126930 | Apr 28, 2023 | Dec 31, 2022 |
| 8-K | 8-K | 0000950170-23-014246 | Apr 25, 2023 | Apr 19, 2023 |
| 3 | FORM 3 SUBMISSION | 0001209191-23-025525 | Apr 25, 2023 | Apr 19, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-025142 | Apr 21, 2023 | Apr 19, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-024220 | Apr 13, 2023 | Apr 11, 2023 |
| 3 | FORM 3 SUBMISSION | 0001209191-23-024221 | Apr 13, 2023 | Apr 11, 2023 |
| 8-K | 8-K | 0000950170-23-012492 | Apr 12, 2023 | Apr 11, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-021201 | Mar 27, 2023 | Mar 23, 2023 |
| S-8 | S-8 | 0000950170-23-008929 | Mar 21, 2023 | — |
| 10-K | 10-K | 0000950170-23-008927 | Mar 21, 2023 | Dec 31, 2022 |
| 8-K | 8-K | 0000950170-23-007304 | Mar 10, 2023 | Mar 7, 2023 |